Download PDF
CC BY-NC-ND 4.0 · Indian J Radiol Imaging
DOI: 10.1055/s-0044-1801267
Original Article

Vacuum-Assisted Excision of B3 Lesions: A District General Hospital Experience

Anu Sandhya 
1   Breast Surgery Department, Canada Avenue Surrey and Sussex National Health Service Healthcare Redhill, London, United Kingdom
,
Qurat Ul Ain Tahir
2   Dow University of Health Sciences, Pakistan
,
Keerthanaa Veerapatheran
3   Surrey and Sussex NHS Healthcare Redhill, London, United Kingdom
› Author Affiliations Funding None.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Objective The objective of this study was to evaluate the efficacy of utilizing vacuum-assisted excision (VAE) for the management of B3 lesions and to determine the rate of malignant upgrades.

Materials and Methods This observational study was conducted at Surrey and Sussex NHS Healthcare Redhill. All patients with B3 histology on core biopsy from October 2019 to October 2022 were included in the study. The upgrades in both the B3 group with atypia and the B3 group without atypia were examined in terms of ductal carcinoma in situ (DCIS), invasive status, and grade. The data obtained were analyzed using the SPSS version 21.

Results About 65% of the participants in the present study have B3 lesions in their left breast and 43% of the participants have lesions located in the upper inner area of the breast. The majority of the participants in the study had B3 lesions without atypia (75%). In 70 participants, VAE was performed. Out of 70 participants, only 15 had lesion upgrade after VAE (21.4%). Post-VAE follow-up planning was discussed in multidisciplinary team as per the National Health Service breast screening guidelines.

Conclusion The utilization of VAE is a viable alternative strategy for the treatment of B3 lesions, resulting in a decrease in the necessity for invasive surgical interventions. This observational study shows the efficacy of a less invasive procedure in replacement of a surgical procedure producing optimal long-term benefit and less side effects.

Keywords

B3 lesion - breast surgery - breast surgery - malignancy - malignancy - surgical excision - VAE

Authors' Contributions

A.S. was responsible for conceptualization, data curation, formal analysis, methodology, supervision, writing the original draft, and review and editing of the manuscript. Q.A.T. was responsible for formal analysis and writing the original draft. K.V. was responsible for data curation and methodology.


Ethical Approval

Ethical approval was not required for this study as anonymous and retrospective data were used.




Publication History

Article published online:
31 December 2024

© 2024. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin 2023; 73 (01) 17-48
    CrossrefPubMedSearch in Google Scholar
  • 2 Sankatsing VDV, van Ravesteyn NT, Heijnsdijk EAM, de Koning HJ. Authors' reply to: “Questionable method for estimating the influence of mammography screening on breast cancer mortality in the Netherlands”. Int J Cancer 2017; 141 (08) 1709-1710
    CrossrefPubMedSearch in Google Scholar
  • 3 Poorolajal J, Heidarimoghis F, Karami M. et al. Factors for the primary prevention of breast cancer: a meta-analysis of prospective cohort studies. J Res Health Sci 2021; 21 (03) e00520
    CrossrefPubMedSearch in Google Scholar
  • 4 Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A. Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies: an updated review. Cancers (Basel) 2021; 13 (17) 4287
    CrossrefPubMedSearch in Google Scholar
  • 5 Pinder SE, Shaaban A, Deb R. et al. NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions). Clin Radiol 2018; 73 (08) 682-692
    CrossrefPubMedSearch in Google Scholar
  • 6 Bianchi S, Caini S, Renne G. et al; VANCB Study Group. Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-institutional study in Italy. Breast 2011; 20 (03) 264-270
    CrossrefPubMedSearch in Google Scholar
  • 7 Rageth CJ, O'Flynn EAM, Pinker K. et al. Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat 2019; 174 (02) 279-296
    CrossrefPubMedSearch in Google Scholar
  • 8 Houssami N, Ciatto S, Ellis I, Ambrogetti D. Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates. Cancer 2007; 109 (03) 487-495
    CrossrefPubMedSearch in Google Scholar
  • 9 Giannotti E, James JJ, Chen Y. et al. Effectiveness of percutaneous vacuum-assisted excision (VAE) of breast lesions of uncertain malignant potential (B3 lesions) as an alternative to open surgical biopsy. Eur Radiol 2021; 31 (12) 9540-9547
    CrossrefPubMedSearch in Google Scholar
  • 10 Hennessy G, Boland MR, Bambrick M. et al. Value of long-term follow-up in surgically excised lesions of uncertain malignant potential in the breast: is 5 years necessary?. Clin Breast Cancer 2022; 22 (07) 699-704
    CrossrefPubMedSearch in Google Scholar
  • 11 GOV.IN. Clinical guidance for breast cancer screening assessment. Accessed December 5, 2024 at: publishing.service.gov.uk
  • 12 Giannotti E, James JJ, Chen Y. et al. Correction to: Effectiveness of percutaneous vacuum-assisted excision (VAE) of breast lesions of uncertain malignant potential (B3 lesions) as an alternative to open surgical biopsy. Eur Radiol 2022; 32 (01) 742-742
    CrossrefPubMedSearch in Google Scholar
  • 13 Strachan C, Horgan K, Millican-Slater RA, Shaaban AM, Sharma N. Outcome of a new patient pathway for managing B3 breast lesions by vacuum-assisted biopsy: time to change current UK practice?. J Clin Pathol 2016; 69 (03) 248-254
    CrossrefPubMedSearch in Google Scholar
  • 14 Abdulcadir D, Nori J, Meattini I. et al. Phyllodes tumours of the breast diagnosed as B3 category on image-guided 14-gauge core biopsy: analysis of 51 cases from a single institution and review of the literature. Eur J Surg Oncol 2014; 40 (07) 859-864
    CrossrefPubMedSearch in Google Scholar
  • 15 Rakha EA, Ho BC, Naik V. et al. Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia. Histopathology 2011; 58 (04) 626-632
    CrossrefPubMedSearch in Google Scholar
  • 16 El-Sayed ME, Rakha EA, Reed J, Lee AH, Evans AJ, Ellis IO. Audit of performance of needle core biopsy diagnoses of screen detected breast lesions. Eur J Cancer 2008; 44 (17) 2580-2586
    CrossrefPubMedSearch in Google Scholar
  • 17 Rakha EA, Lee AH, Jenkins JA, Murphy AE, Hamilton LJ, Ellis IO. Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Int J Cancer 2011; 129 (06) 1417-1424
    CrossrefPubMedSearch in Google Scholar
  • 18 Mayer S, Kayser G, Rücker G. et al. Absence of epithelial atypia in B3-lesions of the breast is associated with decreased risk for malignancy. Breast 2017; 31: 144-149
    CrossrefPubMedSearch in Google Scholar
  • 19 Forrai G, Kovács E, Ambrózay É. et al. Use of diagnostic imaging modalities in modern screening, diagnostics and management of breast tumours 1st central-eastern European professional consensus statement on breast cancer. Pathol Oncol Res 2022; 28: 1610382
    CrossrefPubMedSearch in Google Scholar
  • 20 Mathew J, Crawford DJ, Lwin M, Barwick C, Gash A. Ultrasound-guided, vacuum-assisted excision in the diagnosis and treatment of clinically benign breast lesions. Ann R Coll Surg Engl 2007; 89 (05) 494-496
    CrossrefPubMedSearch in Google Scholar
  • 21 Alonso-Bartolomé P, Vega-Bolívar A, Torres-Tabanera M. et al. Sonographically guided 11-G directional vacuum-assisted breast biopsy as an alternative to surgical excision: utility and cost study in probably benign lesions. Acta Radiol 2004; 45 (04) 390-396
    CrossrefPubMedSearch in Google Scholar
  • 22 Sharma N, Wilkinson LS, Pinder SE. The B3 conundrum-the radiologists' perspective. Br J Radiol 2017; 90 (1071): 20160595
    CrossrefPubMedSearch in Google Scholar